SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-121662
Filing Date
2021-10-01
Accepted
2021-10-01 08:36:26
Documents
12
Period of Report
2021-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128927d1_8k.htm   iXBRL 8-K 26215
  Complete submission text file 0001104659-21-121662.txt   201613

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mxct-20210930.xsd EX-101.SCH 3186
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20210930_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20210930_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2128927d1_8k_htm.xml XML 3707
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 211297212
SIC: 8731 Services-Commercial Physical & Biological Research